Unique ID issued by UMIN | UMIN000015981 |
---|---|
Receipt number | R000018589 |
Scientific Title | Cerebral Blood Flow Measurement of MRI using O-17 labeled water in Normal Subjects and Patients with Chronic Cerebrovascular Disorders |
Date of disclosure of the study information | 2015/01/05 |
Last modified on | 2019/03/03 00:10:43 |
Cerebral Blood Flow Measurement of MRI using O-17 labeled water in Normal Subjects and Patients with Chronic Cerebrovascular Disorders
Cerebral Blood Flow Measurement using O-17 labeled water
Cerebral Blood Flow Measurement of MRI using O-17 labeled water in Normal Subjects and Patients with Chronic Cerebrovascular Disorders
Cerebral Blood Flow Measurement using O-17 labeled water
Japan |
normal subjects and patients with chronic cerebrovascular disorders
Radiology | Adult |
Others
NO
feasibility evaluation of O-17 labeled water
Efficacy
Exploratory
Pragmatic
Not applicable
Signal difference of brain parenchyma between pre- and post-administration of O-17 labeled water and saline
(1)Efficacy
1)Temporal signal change after administration of O-17 labeled water and saline
2)Correlation between blood flow image and PET in patient group
(2)Safety
1) Vital signs (BP, HR, body temperature)
2) Adverse effect
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Prevention
Medicine |
intravenous administration of O-17 labeled water
20 | years-old | <= |
65 | years-old | > |
Male
Step1(Normal subjects)
(1)healthy Japanese male (20 - 65 years old)
(2)body weight < 60 kg
(3)informed consent is obtained
Step2(Patients)
(1)Stenosis or occlusion of major craniocervical arteries in MRA, diagnosed within 90 days before obtaining informed consent
(2)Diminished regional cerebral blood flow (CBF) in SPECT/PET, diagnosed within 90 days before obtaining informed consent
(3)Japanese male (20 - 65 years old)
(4)body weight < 60 kg
(5)informed consent is obtained
Step1(Normal subjects)
(1)metallic implant or claustrophobia
(2)chronic disorders
(3)CNS, liver, kidney or heart diease
(4)acute infection before 30 days
(5)drug allergy
(6)chronic intake of drugs (> 30 days)
(7)other clinical trial
(8)willing to have babies
(9)person who is contraindicated for this study due to other reasons
Step2(Patients)
(1)metallic implant or claustrophobia
(2)unstable cardiac function
(3)severe hepatic or renal disorders
(4)acute infection before 30 days
(5)drug allergy
(6)screening test
(7)willing to have babies
(8)other clinical trial
(9)person who is contraindicated for this study due to other reasons
23
1st name | |
Middle name | |
Last name | Kohsuke Kudo |
Hokkaido University Hospital
department of radiology
Kita 14 Nishi 5, Kita-ku, Sapporo, Hokkaido
011-716-1161
kkudo@huhp.hokudai.ac.jp
1st name | |
Middle name | |
Last name | Kohsuke Kudo |
Hokkaido University Hospital
department of radiology
Kita 14 Nishi 5, Kita-ku, Sapporo, Hokkaido
011-716-1161
kkudo@huhp.hokudai.ac.jp
Hokkaido University Hospital
Japan Agency for Medical Research and Development (AMED)/Translational Research Network Program
Other
NO
2015 | Year | 01 | Month | 05 | Day |
Unpublished
Completed
2014 | Year | 12 | Month | 17 | Day |
2015 | Year | 01 | Month | 05 | Day |
2014 | Year | 12 | Month | 17 | Day |
2019 | Year | 03 | Month | 03 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000018589